Stem Cell Banking

About Bright Cell

Bright Cell is a private, early-stage biotech firm founded in 2018 and headquartered in Boston, with an operational address in Irvine, California. The company is developing a pipeline of stem cell-based therapeutic candidates, some of which are in US FDA-regulated clinical trials, while also offering commercial services in R&D, CDMO, and cell banking. Its business model combines therapeutic development with service revenue, positioning it in the high-growth regenerative medicine market, though it faces significant risks common to pre-revenue biotech ventures, including clinical trial outcomes and funding needs.

Other N/A - Service Drugs